Genzyme Expects Fabrazyme Approval Before Confirmatory Trial Completion
Genzyme expects to receive FDA approval for its Fabry disease therapy Fabrazyme prior to the January 2004 completion of a confirmatory efficacy study
Genzyme expects to receive FDA approval for its Fabry disease therapy Fabrazyme prior to the January 2004 completion of a confirmatory efficacy study